NO992552D0 - Preparat inneholdende diarylalkanderivat som aktiv bestanddel for behandling eller forhindring av pankreatitt - Google Patents

Preparat inneholdende diarylalkanderivat som aktiv bestanddel for behandling eller forhindring av pankreatitt

Info

Publication number
NO992552D0
NO992552D0 NO992552A NO992552A NO992552D0 NO 992552 D0 NO992552 D0 NO 992552D0 NO 992552 A NO992552 A NO 992552A NO 992552 A NO992552 A NO 992552A NO 992552 D0 NO992552 D0 NO 992552D0
Authority
NO
Norway
Prior art keywords
pancreatitis
prevention
treatment
active ingredient
preparation containing
Prior art date
Application number
NO992552A
Other languages
English (en)
Other versions
NO992552L (no
Inventor
Fumitoshi Asai
Koichi Fujimoto
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO992552D0 publication Critical patent/NO992552D0/no
Publication of NO992552L publication Critical patent/NO992552L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO992552A 1996-11-28 1999-05-27 Preparat inneholdende diarylalkanderivat som aktiv bestanddel for behandling eller forhindring av pankreatitt NO992552L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31774696 1996-11-28
PCT/JP1997/004323 WO1998023271A1 (fr) 1996-11-28 1997-11-27 Composition contenant un derive de diarylalcane en tant que principe actif destinee au traitement ou a la prevention de pancreatite

Publications (2)

Publication Number Publication Date
NO992552D0 true NO992552D0 (no) 1999-05-27
NO992552L NO992552L (no) 1999-07-19

Family

ID=18091579

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992552A NO992552L (no) 1996-11-28 1999-05-27 Preparat inneholdende diarylalkanderivat som aktiv bestanddel for behandling eller forhindring av pankreatitt

Country Status (12)

Country Link
EP (1) EP0958817A1 (no)
KR (1) KR20000057309A (no)
CN (1) CN1245426A (no)
AU (1) AU717679B2 (no)
CA (1) CA2273085A1 (no)
CZ (1) CZ189299A3 (no)
HU (1) HUP9904002A3 (no)
ID (1) ID21653A (no)
IL (1) IL130103A0 (no)
NO (1) NO992552L (no)
NZ (1) NZ336003A (no)
WO (1) WO1998023271A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090093493A1 (en) * 2007-10-09 2009-04-09 Francesco Berardi 1-phenylalcoxy-2-beta-phenylethyl derivatives as p-glycoprotein (p-gp) inhibitors useful in drug resistance events

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0441472A (ja) * 1990-06-05 1992-02-12 Sankyo Co Ltd グアニジノ安息香酸エステル誘導体
NO300539B1 (no) * 1992-11-30 1997-06-16 Sankyo Co alfa,omega-diarylalkanderivater, med terapeutisk aktivitet for behandling og forhindring av sirkulasjonssykdommer og psykoser, og farmasöytiske preparater inneholdende disse derivater
JP3154884B2 (ja) * 1992-12-18 2001-04-09 三共株式会社 脂環式アミン誘導体

Also Published As

Publication number Publication date
NO992552L (no) 1999-07-19
HUP9904002A3 (en) 2001-01-29
HUP9904002A2 (hu) 2000-04-28
KR20000057309A (ko) 2000-09-15
AU5067198A (en) 1998-06-22
IL130103A0 (en) 2000-06-01
EP0958817A1 (en) 1999-11-24
CN1245426A (zh) 2000-02-23
CZ189299A3 (cs) 1999-09-15
AU717679B2 (en) 2000-03-30
NZ336003A (en) 2001-02-23
WO1998023271A1 (fr) 1998-06-04
ID21653A (id) 1999-07-08
CA2273085A1 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
AR027162A1 (es) Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen
DK0753506T3 (da) 6-Dimethylaminomethyl-1-phenyl-cyclohexanforbindelser som farmaceutisk aktive stoffer
DK0780369T3 (da) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-forbindelser som farmaceutisk virksomme stoffer
NO308107B1 (no) Ikke-solvatert krystallinsk forbindelse, farmasøytisk formulering inneholdende denne samt anvendelse av forbindelsen for fremstilling av et farmasøytisk middel
IT1283102B1 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
NO995500D0 (no) Anvendelse av en farmasöytisk sammensetning til behandling av/eller forhindring av ischemi
DE69509650T2 (de) Behandlung atrialer fibrillationen
NO20003150D0 (no) FremgangsmÕte for fremstilling av tabletter som oppløses ved tygging
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
NO20002443L (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
NO964639L (no) Substituerte sulfonimidamider, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikament inneholdende forbindelsen
NO991407D0 (no) Legemiddelaerosolformuleringer som omfatter budesonid
NO970610D0 (no) Sammensetning for selektiv frigjöring av en aktiv ingrediens
NO990435L (no) Fremstilling av estere som overflateaktive midler
NO911956L (no) Fremgangsmaate for fremstilling av oxydant sensitive og insensitive, aromatiske estere som inhibitorer for human neutrofil elastase
NO20006646D0 (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
DE59909341D1 (de) Retardformulierungen von pflanzenschutzwirkstoffen
NO982754D0 (no) Fosfolipidderivater av fosfonokarboksylsyrer, fremstilling av slike derivater og anvendelse av derivatene som antivirusmedikamenter
NO992562D0 (no) Anvendelse av blandinger av aktive bestanddeler, inneholdende phytostenoler og/eller phytostenol-estere og potensieringsmidler, for fremstilling av hypo-kolesterinemiske midler
NO306347B1 (no) Eleutherobin og analoger av denne, anvendelse av forbindelsen samt farmasöytisk preparat inneholdende denne
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
FI934064A (fi) Anvaendning av tiadiazolfoereningar som aktivt aemne foer foerebyggande av bottenvaextlighet hos fartyg
NO992552D0 (no) Preparat inneholdende diarylalkanderivat som aktiv bestanddel for behandling eller forhindring av pankreatitt
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application